Synthesis, Structural Characterization, and Guest Exchange Properties of Hydrogen-Bonded Organic Frameworks Based on Bis(benzimidazole)ZnCl2 Complexes.

Hydrogen-bonded organic frameworks (HOFs) based on coordination compounds constitute a developing class of interesting porous materials. Herein, we report on the synthesis, crystal structures, and guest exchange properties of four HOFs based on zinc dichlorido complexes that bear a bis(benzimidazolyl)methane ligand (bis(benzimidazole)ZnCl2). The porous structures of these bis(benzimidazole)ZnCl2-based HOFs are characterized predominantly by intermolecular N-H···Cl hydrogen bonds in conjunction with π-π interactions. One of these HOFs was found to exchange guest molecules via single-crystal-to-single-crystal transformations with or without structural change. A single-crystal X-ray diffraction study revealed that the guest exchange accompanied by a structural change is induced by the cleavage of the N-H···Cl hydrogen bonds between the bis(benzimidazole)ZnCl2 complexes, followed by the formation of alternate hydrogen bonds with guest molecules. This result suggests that the use of weaker N-H···Cl hydrogen bonds than those typically used for the construction of HOFs (e.g., carboxylic acid dimers, N-heterocycles, and charge-assisted moieties) may represent a convenient strategy to synthesize flexible HOFs.

Synthesis, Structures, and Solution Dynamics of Titanium and Zirconium Complexes Carrying a Bis(indolyl) and Two Diethylamido Ligands.

Indolyl is the anionic species obtained from the deprotonation of the N-H group of indole. Group 4 transition-metal complexes that carry indolyl-based polydentate ligands represent promising homogeneous catalysts for, e.g., olefin polymerization, hydroamination, and nitrogen-fixation reactions due to the weak π-donation and electron-withdrawing properties, as well as the low basicity of indolyl. In this study, we systematically investigated the synthesis and structures of titanium and zirconium complexes that carry deprotonated 2,2'-bis(indolyl)methane ligands (henceforth: bis(indolyl) ligands) and two diethylamido ligands. We found that the coordination geometry of the indolyl nitrogen atom in such bis(indolyl) ligands is affected by the steric impact of the substituents attached to the central aromatic ring. Moreover, we examined the dynamics of such bis(indolyl) ligands in solution for the corresponding zirconium complexes, and the mechanism was discussed in conjunction with DFT calculations. The results of this study suggest that bis(indolyl) ligands may also serve as coordinatively flexible ancillary ligands, and indicate the feasibility of an expansion from bis(indolyl) to bis(indolyl)-donor ligands.

Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.

INTRODUCTION: Progranulin (PGRN), a pleiotropic growth factor, has emerged as an immunoregulatory molecule. Because the roles of PGRN in dermatomyositis (DM) are still unknown, we investigated whether serum PGRN levels are associated with disease activity and prognosis in DM patients, particularly in those with DM complicated with interstitial lung disease (ILD). METHODS: The serum levels of PGRN were measured by enzyme-linked immunosorbent assay in patients with DM (n=57; acute/subacute interstitial pneumonia (A/SIP): n=17, chronic interstitial pneumonia (CIP): n=24, without ILD: n=16), polymyositis (PM, n=21; including 6 with ILD) and normal healthy controls (NHCs, n=60). We assessed the correlation between the serum PGRN levels and the activity indexes of ILD or prognosis in DM patients with ILD. RESULTS: Serum PGRN levels were significantly higher in DM patients than in PM patients (P=0.0025) and in NHCs (P<0.0001). In DM patients, the levels were significantly higher in patients with A/SIP than in those with CIP (P<0.0001) or without ILD (P=0.0003). The serum PGRN levels in DM patients with ILD significantly correlated with serum ferritin (rS=0.77, P<0.0001), lactate dehydrogenase (rS=0.54, P=0.0003) and C-reactive protein (rS=0.48, P=0.0015) levels. Moreover, in DM patients with ILD, the cumulative survival rate for 6 months was significantly lower in the group with serum PGRN levels≥200 ng/ml (67%) than in the group with serum PGRN levels<200 ng/ml (100%) (P=0.0009). CONCLUSIONS: Serum PGRN is associated with disease activity and prognosis of DM with ILD. PGRN may play a role in the pathogenesis of DM and could be a useful biomarker.

The cytotoxic effects of certolizumab pegol and golimumab mediated by transmembrane tumor necrosis factor α.

BACKGROUND: Anti-tumor necrosis factor α (anti-TNF-α) agents have been successfully applied for the treatment of rheumatoid arthritis, Crohn's disease, and other chronic inflammatory diseases. Not only the neutralization of soluble TNF-α but also the effect on transmembrane TNF-α is important mechanisms of action of anti-TNF-α agents. This study investigated the cytotoxic effects of new anti-TNF-α agents, certolizumab pegol and golimumab, which are mediated by transmembrane TNF-α. METHODS: Transmembrane TNF-α-expressing Jurkat T cells that did not express TNF receptors were used. The binding ability of each anti-TNF-α agent to transmembrane TNF-α, antibody-dependent cell-mediated cytotoxicity, complement-dependent cytotoxicity, and the apoptotic effect were examined. RESULTS: Certolizumab pegol and golimumab bound to transmembrane TNF-α. Golimumab induced antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity, which was comparable to infliximab and adalimumab. However, certolizumab pegol did not induce antibody-dependent cell-mediated cytotoxicity or complement-dependent cytotoxicity. Certolizumab pegol directly induced nonapoptotic cell death in transmembrane TNF-α-expressing cells. Golimumab induced a weaker apoptotic effect than infliximab and adalimumab. CONCLUSIONS: The cytotoxic effects of anti-TNF-α agents on TNF-α-expressing cells are considered to be associated with the clinical effect of these agents on granulomatous diseases. The direct cytotoxic effect of certolizumab pegol on TNF-α-producing cells may contribute to its clinical efficacy in Crohn's disease. Golimumab may be less effective for granulomatous diseases.

Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.

INTRODUCTION: Progranulin (PGRN) is the precursor of granulin (GRN), a soluble cofactor for toll-like receptor 9 (TLR9) signaling evoked by oligonucleotide (CpG)-DNA. Because TLR9 signaling plays an important role in systemic lupus erythematosus (SLE), we investigated whether PGRN is involved in the pathogenesis of SLE. METHODS: We measured concentrations of serum PGRN and interleukin-6 (IL-6) with enzyme-linked immunosorbent assay (ELISA) in patients with SLE (n = 68) and in healthy controls (n = 60). We assessed the correlation between the serum PGRN levels and established disease-activity indexes. The sera from the patients with high PGRN titers (>80 ng/ml) at the initial evaluation were reevaluated after the disease was ameliorated by treatment. We also measured the IL-6 concentration secreted by peripheral blood mononuclear cells (PBMCs) incubated with (a) oligonucleotide (CpG-B) in the presence or absence of recombinant human PGRN (rhPGRN); and (b) lupus sera in the presence or absence of a neutralizing anti-PGRN antibody. RESULTS: Serum PGRN levels were significantly higher in SLE patients than healthy controls. Their levels were significantly associated with activity of clinical symptoms. They also significantly correlated with values of clinical parameters, including the SLE Disease Activity Index and anti-double-stranded DNA antibody titers, and inversely with CH50, C3, and C4 levels. Moreover, serum PGRN levels significantly decreased after successful treatment of SLE. The rhPGRN significantly upregulated the production of IL-6 by PBMCs stimulated with CpG-B. Patients' sera stimulated production of IL-6 from PBMCs, which was significantly impaired by neutralization of PGRN. The serum PGRN levels significantly correlated with the serum IL-6 levels. CONCLUSIONS: Serum PGRN could be a useful biomarker for disease activity of SLE. PGRN may be involved in the pathogenesis of SLE partly by enhancing the TLR9 signaling.

A nitrogenase cluster model [Fe8S6O] with an oxygen unsymmetrically bridging two proto-Fe4S3 cubes: relevancy to the substrate binding mode of the FeMo cofactor.

An oxygen-encapsulated iron sulfido cluster, [(DmpS)Fe(4)S(3)O][(DmpS)Fe(4)S(3)](µ-SDmp)(2)(µ-OCPh(3)) (2; Dmp = 2,6-(mesityl)(2)C(6)H(3)), has been synthesized by the reaction of the preformed dinuclear iron thiolate/alkoxide [(Ph(3)CO)Fe](2)(µ-SDmp)(2) (1) with (1/8)S(8) and (1/4)H(2)O in toluene. In the [Fe(8)S(6)O] core, the oxygen atom bridges unsymmetrically two incomplete Fe(4)S(3) cubes, and two coordinatively unsaturated iron atoms are weakly bound to mesityl rings. Relevance of the cluster structure of 2 to the nitrogenase FeMo cofactor and its substrate binding mode is discussed.

Oxido-bridged di-, tri-, and tetra-nuclear iron complexes bearing bis(trimethylsilyl)amide and thiolate ligands.

A series of di-, tri-, and tetra-nuclear iron-oxido clusters with bis(trimethylsilyl)amide and thiolate ligands were synthesized from the reactions of Fe{N(SiMe(3))(2)}(2) (1) with 1 equiv of thiol HSR (R = C(6)H(5) (Ph), 4-(t)BuC(6)H(4), 2,6-Ph(2)C(6)H(3) (Dpp), 2,4,6-(i)Pr(3)C(6)H(2) (Tip)) and subsequent treatment with O(2). The trinuclear clusters [{(Me(3)Si)(2)N}Fe](3)(µ(3)-O){µ-S(4-RC(6)H(4))}(3) (R = H (3a), (t)Bu (3b)) were obtained from the reactions of 1 with HSPh or HS(4-(t)BuC(6)H(4)) and O(2), while we isolated a tetranuclear cluster [{(Me(3)Si)(2)N}(2)Fe(2)(µ-SDpp)](2)(µ(3)-O)(2) (4) as crystals from an analogous reaction with HSDpp. Treatment of a tertrahydrofuran (THF) solution of 1 with HSTip and O(2) resulted in the formation of a dinuclear complex [{(Me(3)Si)(2)N}(TipS)(THF)Fe](2)(µ-O) (5). The molecular structures of these complexes have been determined by X-ray crystallographic analysis.

Synthesis, structures, and electronic properties of [8Fe-7S] cluster complexes modeling the nitrogenase P-cluster.

High-yield synthesis of the iron-sulfur cluster [{N(SiMe(3))(2)}{SC(NMe(2))(2)}Fe(4)S(3)](2)(mu(6)-S) {mu-N(SiMe(3))(2)}(2) (1), which reproduces the [8Fe-7S] core structure of the nitrogenase P(N)-cluster, has been achieved via two pathways: (1) Fe{N(SiMe(3))(2)}(2) + HSTip (Tip = 2,4,6-(i)Pr(3)C(6)H(2)) + tetramethylthiourea (SC(NMe(2))(2)) + elemental sulfur (S(8)); and (2) Fe(3){N(SiMe(3))(2)}(2)(mu-STip)(4) (2) + HSTip + SC(NMe(2))(2) + S(8). The thiourea and terminal amide ligands of 1 were found to be replaceable by thiolate ligands upon treatment with thiolate anions and thiols at -40 degrees C, respectively, and a series of [8Fe-7S] clusters bearing two to four thiolate ligands have been synthesized and their structures were determined by X-ray analysis. The structures of these model [8Fe-7S] clusters all closely resemble that of the reduced form of P-cluster (P(N)) having 8Fe(II) centers, while their 6Fe(II)-2Fe(III) oxidation states correspond to the oxidized form of P-cluster (P(OX)). The cyclic voltammograms of the [8Fe-7S] clusters reveal two quasi-reversible one-electron reduction processes, leading to the 8Fe(II) state that is the same as the P(N)-cluster, and the synthetic models demonstrate the redox behavior between the two major oxidation states of the native P-cluster. Replacement of the SC(NMe(2))(2) ligands in 1 with thiolate anions led to more negative reduction potentials, while a slight positive shift occurred upon replacement of the terminal amide ligands with thiolates. The clusters 1, (NEt(4))(2)[{N(SiMe(3))(2)}(SC(6)H(4)-4-Me)Fe(4)S(3)](2)(mu(6)-S){mu-N(SiMe(3))(2)}(2) (3a), and [(SBtp){SC(NMe(2))(2)}Fe(4)S(3)](2)(mu(6)-S){mu-N(SiMe(3))(2)}(2) (5; Btp = 2,6-(SiMe(3))(2)C(6)H(3)) are EPR silent at 4-100 K, and their temperature-dependent magnetic moments indicate a singlet ground state with antiferromagnetic couplings among the iron centers. The (57)Fe Mössbauer spectra of these clusters are consistent with the 6Fe(II)-2Fe(III) oxidation state, each exhibiting two doublets with an intensity ratio of ca. 1:3, which are assignable to Fe(III) and Fe(II), respectively. Comparison of the quadrupole splittings for 1, 3a, and 5 has led to the conclusion that two Fe(III) sites of the clusters are the peripheral iron atoms.